Abstract
Background: Periodontitis is a localized inflammatory disorder. If not treated timely, the disease can result in loosening and subsequent loss of teeth. In situ hydrogel prepared with phase separation technique has emerged as an attractive alternative for periodontal pocket injection.
Objective: Minocycline (MCL)-loaded in situ hydrogel was prepared composed of poly(lactide-coglycolide) (PLGA) and N-methylpyrrolidone (NMP) to improve the topical treatment effect of periodontitis.
Method: A series of reasonable and applicable formulations were optimized by investigating their syringeability, viscosity and in vitro drug release. The rheological profiles, antimicrobial activities and pharmacodynamics were further studied to evaluate its effect on periodontitis treatment.
Results: The prepared MCL/PLGA hydrogel exhibited the characteristic of Newton fluid with acceptable syringeability. Drug release could last for more than 48 hours with an acceptable “burst release”. It also had obvious antimicrobial activities and pharmacodynamics efficiency similar to the commercial product, Parocline®.
Conclusion: MCL/PLGA in situ hydrogel may be a promising clinical formulation for periodontitis treatment.
Keywords: Antibacteria, burst release, in situ hydrogel, minocycline, periodontitis, poly(lactic-co-glycolic acid) (PLGA).
Graphical Abstract
Current Drug Delivery
Title:Minocycline-loaded In situ Hydrogel for Periodontitis Treatment
Volume: 15 Issue: 5
Author(s): Xiaoqing Wang*, Jianli Ma*, Xiaoming Zhu, Fang Wang and Liang Zhou
Affiliation:
- Department of Pharmacy, the First Affiliated Hospital of General Hospital of PLA, Beijing,China
- Department of Pharmacy, the First Affiliated Hospital of General Hospital of PLA, Beijing,China
Keywords: Antibacteria, burst release, in situ hydrogel, minocycline, periodontitis, poly(lactic-co-glycolic acid) (PLGA).
Abstract: Background: Periodontitis is a localized inflammatory disorder. If not treated timely, the disease can result in loosening and subsequent loss of teeth. In situ hydrogel prepared with phase separation technique has emerged as an attractive alternative for periodontal pocket injection.
Objective: Minocycline (MCL)-loaded in situ hydrogel was prepared composed of poly(lactide-coglycolide) (PLGA) and N-methylpyrrolidone (NMP) to improve the topical treatment effect of periodontitis.
Method: A series of reasonable and applicable formulations were optimized by investigating their syringeability, viscosity and in vitro drug release. The rheological profiles, antimicrobial activities and pharmacodynamics were further studied to evaluate its effect on periodontitis treatment.
Results: The prepared MCL/PLGA hydrogel exhibited the characteristic of Newton fluid with acceptable syringeability. Drug release could last for more than 48 hours with an acceptable “burst release”. It also had obvious antimicrobial activities and pharmacodynamics efficiency similar to the commercial product, Parocline®.
Conclusion: MCL/PLGA in situ hydrogel may be a promising clinical formulation for periodontitis treatment.
Export Options
About this article
Cite this article as:
Wang Xiaoqing *, Ma Jianli *, Zhu Xiaoming , Wang Fang and Zhou Liang , Minocycline-loaded In situ Hydrogel for Periodontitis Treatment, Current Drug Delivery 2018; 15 (5) . https://dx.doi.org/10.2174/1567201814666171120120421
DOI https://dx.doi.org/10.2174/1567201814666171120120421 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Matrix Metalloproteinase Inhibitors: A Review on Pharmacophore Mapping and (Q)Sars Results
Current Medicinal Chemistry Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Top-Down Versus Bottom-Up Nanoengineering Routes to Design Advanced Oropharmacological Products
Current Pharmaceutical Design Achieving Functionality Through Modular Build-up: Structure and Size Selection of Serine Oligopeptidases
Current Protein & Peptide Science Teeth with Apical Periodontitis Obturated in the Presence or Absence of Cultivable Micro-Organisms: A Two-Year Prospective Study of Treatment Outcomes
Current Dentistry Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone Turnover: An Evidence-Based Review
Reviews on Recent Clinical Trials The Effect of Acori Graminei Rhizoma and Extract Fractions on Spatial Memory and Hippocampal Neurogenesis in Amyloid Beta 1-42 Injected Mice
CNS & Neurological Disorders - Drug Targets The Inflammation Paradigm and Coronary Artery Disease: What Celsus, Virchow and Gene Knock Outs Have Taught Us
Cardiovascular & Hematological Disorders-Drug Targets Extracellular Proteases as Targets for Drug Development
Current Protein & Peptide Science Drug in Adhesive Transdermal Formulation of Valsartan and Nifedipine: Pharmacokinetics and Pharmacodynamics in Rats
Current Drug Therapy Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets Aquaporins and Glia
Current Neuropharmacology The Potential Therapeutic Role of the HMGB1-TLR Pathway in Epilepsy
Current Drug Targets On the Paradigm Shift Towards Multitarget Selective Drug Design
Current Computer-Aided Drug Design Associations between Periodontitis and Systemic Inflammatory Diseases: Response to Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Biomaterials for Gene Delivery Atelocollagen-mediated Controlled Release of Molecular Medicines
Current Gene Therapy Effect of Chitosan, Chitosan Nanoparticle, Anacyclus pyrethrum and Cyperus rotundus in Combating Plasmid Mediated Resistance in Periodontitis
Anti-Infective Agents How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design Is the Treatment with Biological or Non-biological DMARDS a Modifier of Periodontal Condition in Patients with Rheumatoid Arthritis?
Current Rheumatology Reviews New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics
Current Pharmaceutical Design